These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 2860059)
21. Epitope mapping the Fim2 and Fim3 proteins of Bordetella pertussis with sera from patients infected with or vaccinated against whooping cough. Williamson P; Matthews R FEMS Immunol Med Microbiol; 1996 Feb; 13(2):169-78. PubMed ID: 8731026 [TBL] [Abstract][Full Text] [Related]
22. Immunity to pertussis. Not all virulence factors are protective antigens. Robbins JB; Schneerson R; Bryla DA; Trollfors B; Taranger J; Lagergård T Adv Exp Med Biol; 1998; 452():207-18. PubMed ID: 9889975 [TBL] [Abstract][Full Text] [Related]
24. Protective activities of "Bordetella pertussis" Tn5 mutants in mice. Olander RM; Muotiala A; Parviainen T; Runeberg-Nyman K Ann Sclavo Collana Monogr; 1986; 3(1-2):329-35. PubMed ID: 2892513 [No Abstract] [Full Text] [Related]
25. Development and clinical testing of an acellular pertussis vaccine containing genetically detoxified pertussis toxin. Rappuoli R; Pizza M; De Magistris MT; Podda A; Bugnoli M; Manetti R; Nencioni L Immunobiology; 1992 Feb; 184(2-3):230-9. PubMed ID: 1587545 [TBL] [Abstract][Full Text] [Related]
26. Secretory IgA against pertussis toxin and surface structures of Bordetella pertussis in saliva of children with culture proven pertussis. Frühwirth M; Wolf H; Heininger H; Guggenbichler JP; Stehr E Adv Exp Med Biol; 1995; 371B():777-83. PubMed ID: 7502896 [No Abstract] [Full Text] [Related]
28. Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis. Pittman M Rev Infect Dis; 1979; 1(3):401-12. PubMed ID: 233166 [TBL] [Abstract][Full Text] [Related]
29. Further contributions to an improved pertussis vaccine: II. New findings in the development of a pertussis vaccine. Robbel L; Hungerer KD; Aktories K Behring Inst Mitt; 1984 Nov; (76):110-2. PubMed ID: 6098261 [No Abstract] [Full Text] [Related]
30. Pitfalls in the preparation of monotypic agglutinating antisera for Bordetella pertussis. Holt LB J Med Microbiol; 1968 Nov; 1(2):169-80. PubMed ID: 4318535 [No Abstract] [Full Text] [Related]
31. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis. Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077 [TBL] [Abstract][Full Text] [Related]
32. [Immunologic findings in oral pertussis vaccination]. Kurz R; Mayr J; Höfler KH; Falk W; Rosanelli K Padiatr Padol; 1986; 21(1):53-9. PubMed ID: 2870453 [TBL] [Abstract][Full Text] [Related]
34. Engineering bacterial toxin for the development of new vaccine against pertussis. Bartoloni A; Pizza M; Gross R; Perugini M; Arico B; Domenighini M; Rappuoli R Tokai J Exp Clin Med; 1988; 13 Suppl():217-22. PubMed ID: 2483870 [TBL] [Abstract][Full Text] [Related]
36. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough]. Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215 [TBL] [Abstract][Full Text] [Related]
37. Local and systemic immune responses to pertussis infection and cellular and acellular vaccines. Ashworth LA; Day A; Lambert HP; Lingham S; Lissauer T; Miller E; Robinson A; Rutter DA; Thomas MG Ann Sclavo Collana Monogr; 1986; 3(1-2):199-211. PubMed ID: 2892507 [No Abstract] [Full Text] [Related]
38. [Acellular pertussis vaccine]. Wiedermann G; Ambrosch F; Vanura H Wien Med Wochenschr; 1991; 141(12):270-2. PubMed ID: 1949820 [TBL] [Abstract][Full Text] [Related]
39. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model. Komatsu E; Yamaguchi F; Eguchi M; Watanabe M Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876 [TBL] [Abstract][Full Text] [Related]
40. Serum IgG antibody response to pertussis toxin in persons for whom pertussis vaccination failed depends upon the number of antigens in the vaccine. Cherry JD Clin Infect Dis; 1999 Mar; 28(3):560-1. PubMed ID: 10194078 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]